Your browser doesn't support javascript.
loading
Somatic mutations in CCK2R alter receptor activity that promote oncogenic phenotypes.
Willard, Melinda D; Lajiness, Mary E; Wulur, Isabella H; Feng, Bo; Swearingen, Michelle L; Uhlik, Mark T; Kinzler, Kenneth W; Velculescu, Victor E; Sjöblom, Tobias; Markowitz, Sanford D; Powell, Steven M; Vogelstein, Bert; Barber, Thomas D.
Affiliation
  • Willard MD; Department of Translational Science, Lilly Research Laboratories, Indianapolis, Indiana 46225, USA. willardme@lilly.com
Mol Cancer Res ; 10(6): 739-49, 2012 Jun.
Article in En | MEDLINE | ID: mdl-22516348

Full text: 1 Database: MEDLINE Main subject: Stomach Neoplasms / Colorectal Neoplasms / Cell Transformation, Neoplastic / Receptor, Cholecystokinin B / Mutation Type of study: Prognostic_studies Limits: Animals / Humans Language: En Year: 2012 Type: Article

Full text: 1 Database: MEDLINE Main subject: Stomach Neoplasms / Colorectal Neoplasms / Cell Transformation, Neoplastic / Receptor, Cholecystokinin B / Mutation Type of study: Prognostic_studies Limits: Animals / Humans Language: En Year: 2012 Type: Article